Top 50 Life Science Angel Investors in United States in January 2025

Investor	Life Science United States investments
Sahin Boydas	5
bumpkins profile	4
Milad Alucozai	4
Kevin Moore	3
Darian Shirazi	3
Esther Dyson	3
Chris Gibson	3
Erik Peterson	3
Kathryn Haun	2
Ankit Jain	2
James Hong	2
Sujay Jaswa	2
Nat Turner	2
David R. Walt	2
Joshua Elkington	2
Patrick Yang	2
Nitesh Banta	2
Joe Betts-Lacroix	2
Patrick Collison	2
Jonathan Milner	2
Jay Zaveri	2
Craig Mundie	2
Peter Harris	2
Mei Z.	2
Brian S. Cohen	2
Michael Chambers	2
Zach Weinberg	2
Elad Gil	2
Lars Fjeldsoe-Nielsen	2
Balaji Srinivasan	2
CJ Reim	2
Kevin Mahaffey	2
Jim Greer	1
Jeff Raikes	1
Ethan Oren Perlstein	1
Lu Yoh-Chie	1
Don Mattrick	1
Evan Cheng	1
Domenic Merenda	1
Norman Sorensen	1
Scott Garber	1
Ling Wong	1
Chloe Sladden	1
Wes Osbourn	1
Jude Gomila	1
Ali Shaaban	1
Daniel Goldman	1
Elliott Sigal	1
Joe Beverly	1
Zen Chu	1

Sahin Boydas is Head of Turkiye, Distributed Teams, Bootcamp, and App Ecosystem at Gusto. He was the CEO & Founder of RemoteTeam. He attended Koç University.

Investment focus

Software, Financial Services, FinTech
Seed, Series A, Series B
United States, Mexico, Spain

Portfolio highlights

Brellium — Clinics use Brellium to automate chart review with AI. Reduce your QA costs by 98%, audit all clinical notes in real time, and decrease clawback risk.
HIFI — HiFi Bridge is a cryptocurrency payments platform that allows customers to buy and sell cryptocurrencies, trade NFT's, borrow loans, and connect their bank accounts all-in-one.The startup offers equity, cryptocurrency, and options trading, as well as cash management accounts. The company provides the accessibility for traditional financialusers to gain access to modern decentralized finance tools through it's mobile and web platform.Zach Walsh and Mohamed Afifi founded the company in New York City in 2021.
CapStack — CapStack is a capital advisory and brokerage firm that assists commercial property owners, investors, and developers in securing finance for commercial properties. The company provides tailored financial solutions and advisory services to help clients navigate the complexities of commercial real estate financing. CapStack leverages its expertise tooffer strategic advice and brokerage services, ensuring that clients can access the necessary capital to achieve their investment goals.

blah - teh software was teh busted and they didn't want to fix it or hire someone to fix it, odd folks, these.

Investment focus

Health Care, Biotechnology, Software
Seed, Series A, Pre-Seed
United States, Canada, India

Portfolio highlights

Sorare — Global Fantasy Football. Collect limited edition digital collectibles, Manage your team and earn prizes!
Hoth Intelligence — Hoth Intelligence home page. Space age surgical technology brought down to earth.
Floating Point Group — Floating Point Group is a trading platform provider offering innovative, industry-leading trade execution and settlement

Dr. Milad Alucozai is an Afghan-American neuroscientist, entrepreneur, biotech executive, and global investor with nearly two decades of experience in deep tech, primarily in life sciences. He pushes the boundaries of bioengineering and computational advancements, integrating machine learning and artificial intelligence into biology and medicine.With a strong commitment to commercializing transformative technologies and fostering startup ecosystems worldwide, he is a thought leader and formal mentor for entrepreneurs through organizations like Creative Destruction Lab and the Wyss Institute at Harvard Medical School.Currently, Milad is the head of Bio and Deep Tech at BoxOne Ventures, where he spearheads the firm’s investments in early-stage companies with breakthrough scientific ideas. With nearly 80 early-stage investments, they are recognized as one of North America’s most active venture firms. He is also a Venture Partner at Entrepreneur First, a global fund that has built over 500 companies from scratch with an enterprise value of $10bn. He supports founders with strategy, scaling, business development, securing growth capital, and leadership training, often being their first investor and guiding them from startup inception to IPOs or acquisitions.He started his career in translational neuroscience and multiphysics laboratories before transitioning into founding roles at biotech startups. He is part of the founding team at Mekonos, a San Francisco-based company creating a proprietary cell-engineering platform to support the future of cell and gene therapies. He was also part of the founding team at Corstem, which specialized in machine learning and artificial intelligence software and was later acquired by Circle Cardiovascular, a platform in over 1000 hospitals and more than 40 countries. At Accenture, Milad directed teams of data scientists, designers, and engineers in developing artificial intelligence platforms for global pharmaceutical companies and hospital networks.Milad serves as a Fellow in Healthcare Engineering at the Regenstrief Center. In 2020, he served as an External Advisor to AstraZeneca. He was recognized as a National Science Foundation Scholar and Macklin Fellow at Johns Hopkins Medicine. He graduated Phi Beta Kappa with a degree in Neuroscience from Purdue University’s Honors Program. As a George J. Mitchell Scholar, he completed his master’s in Immunology and earned his doctorate from the Richard M. Fairbanks School of Public Health.

Investment focus

Biotechnology, Health Care, Medical
Seed, Series A, Pre-Seed
United States, Canada, United Kingdom

Portfolio highlights

Arpeggio Bio — We engineer medicine based not on a single target, but the biological network as a whole.
Future Fields — Future Fields Cellular Agriculture: Serum-Free Growth Media Supplements and Recombinant Proteins - Optimized for the Future of Food.
Eigen Therapeutics — Eigen Therapeutics is a biotechnology company developing combination therapeutics for cancer. The company is in the research and development of synergistic therapies that improve efficacy while reducing the toxicity of small molecule therapies and immunotherapies, enabling physicians to get access to novel drugs in areas of unmet medical needs.

Kevin Moore has 10 years experience as an angel/opportunity investor and operator. Prior to that, he has over 15 years of progressive technology i-banking, corp dev, and CFO experience at startups and $Bn corporates.

Investment focus

Software, Health Care, E-Commerce
Seed, Pre-Seed, Angel
United States, India, Canada

Portfolio highlights

Redbird — Redbird is an operating system that empowers data driven teams to easily create custom applications that automate advanced analytics work in minutes, without writing code.
SilkChart — SilkChart helps growth teams improve campaigns based on what users are doing in product - without relying on expensive data scientists. We do this through a no code analytics tool that combines marketing and product usage data to identify which channels, audiences, and content maximize revenue growth.
Augmend — Create documentation and an AI assistant from any video.

Darian Shirazi is the Managaing Partner of Gradient.

Investment focus

Software, Information Technology, SaaS
Seed, Series A, Series B
United States, Germany, Canada

Portfolio highlights

Valdera — Valdera is the sourcing and procurement platform that makes it easy to buy or sell chemicals, ingredients, and raw materials. We partner with segment leaders, ranging from the world's largest CPG manufacturers to household names in the beauty industry.
Leya — By streamlining and simplifying legal workflows, we empower elite law firms and legal professionals to work more efficiently and effectively. Enabling them to focus on higher-value tasks and deliver exceptional results for their clients.
rift — The sales platform built to help your focus.

Esther Dyson - Founder @ Way to Wellville

Investment focus

Health Care, Software, Medical
Seed, Series A, Funding Round
United States, Canada, Russian Federation

Portfolio highlights

Ezra AI — Ezra provides full-body MRI screening for potential early cancer and abnormalities in up to 13 organs. Book a scan today.
Way — Way combines intuitive eating with behavior science for mindful habits. 73.5% of app users report transformed thinking post-program.
Openwater — OPENWATER - THE FUTURE OF NEURAL DIAGNOSTICS IN THE PALM OF YOUR HAND.

Chris Gibson is the Co-Founder and CEO of Recursion (Recursion Pharmaceuticals). He previously worked at Cure HHT as a Member Board of Directors. Chris Gibson attended the University of Utah.

Investment focus

Biotechnology, Health Care, Life Science
Series A, Seed
United States, France, Switzerland

Portfolio highlights

Amenities Health — Discover your dedicated Digital Front Door platform that enhances the patient experience and foster brand loyalty.
Cradle — Design better proteins
Leash Biosciences — We're transforming drug design with a rich dataset built by screening millions of compounds against thousands of protein to generate billions of data points, ideal for training advanced machine learning models.

Erik Peterson is the Founder at DormTrader.

Investment focus

Software, Biotechnology, SaaS
Seed, Equity Crowdfunding, Series A
United States, Canada, Algeria

Portfolio highlights

Hideout — Hideout makes high-quality food that is available for delivery. Danielle Sobel established the company in Los Angeles, California.
Abalone Bio — Our Functional Antibody Selection Technology platform (FAST) taps into the potential of the body's biological activities, expanding the reach of antibody drugs.
Altay Therapeutics — Altay Therapeutics is a biotech company focused on finding and discovering small molecule therapies for chronic inflammatory conditions. It is currently focused on finding curative therapies for fibrosis, NASH, and liver cancer. It develops novel small molecule drugs against transcriptional regulators that are validated drivers of disease. It wasfounded in 2019 and is headquartered in San Francisco, California.

Katie Haun is a General Partner at Andreessen Horowitz. She serves on the boards of Coinbase and HackerOne and has invested in and advised tech companies from seed to Series E stage. Katie teaches a management course at Stanford Business School and previously taught cybercrime at Stanford Law School. Previously, she spent a decade as a federalprosecutor with the U.S. Department of Justice focusing on fraud, cyber, and corporate crime alongside agencies including the SEC, FBI, and Treasury. She created the government’s first cryptocurrency task force and led investigations into the Mt. Gox hack and the corrupt agents on the Silk Road task force. She also prosecuted RICO murders, organized crime, public corruption, gangs, and money laundering, and held senior policy positions at headquarters in both the National Security Division and Attorney General’s office where her portfolio included antitrust, tax, and national security. Katie clerked for U.S. Supreme Court Justice Anthony Kennedy and is an honors graduate of Stanford Law School.

Investment focus

Blockchain, Financial Services, FinTech
Funding Round, Seed, Series A
United States, United Kingdom

Portfolio highlights

dub — The first Copy-Trading platform for stocks. Copy anyone's investments. For free. Regulated Broker-Dealer member FINRA and SIPC & FDIC insured.
Aptos — Building products, applications, and tooling on the Aptos blockchain. Bringing the benefits of decentralization to the masses.
Primer — Primer is the world's first community built for curious and ambitious kids to find and explore their interests together.

Ankit Jain is the Founder and CEO of Infinitus Systems.

Investment focus

Health Care, Medical, Hospital
Seed, Pre-Seed
United States

Portfolio highlights

Advex AI — Advex AI assists the world's largest manufacturers in cutting costs and increasing productivity by producing highly dependable computer vision models in hours.
RapidClaims — Rapid Claims helps businesses autonomously code medical charts, find up-coding opportunities, improve the CDI process and reduce denials.
Empower Sleep — Empower Sleep provides personalized sleep care online

James Hong

Investment focus

E-Commerce, Software, Internet
Seed, Series A, Angel
United States

Portfolio highlights

Athelas — Our breakthrough technologies provide clarity on a patient's most important health metrics, all while increasing revenue for your practice.
Deep Infra — Deep Infra offers cost-effective, scalable, easy-to-deploy, and production-ready machine-learning models and infrastructures for deep-learning models.
Alchemy — Whether you're a beginner, working on a side project, or one of the largest teams in the blockchain space, Alchemy makes Ethereum development easy with enhanced APIs, node infrastructure, and developer tooling. Get started for free!

Sujay Jaswa is founder and managing partner at WndrCo, a holding company that invests in and acquires consumer technology businesses. He serves as Chairman of Aura, Twingate, VPN Super, and is a Director of The Infatuation. Board member of Vy Global Growth (Nasdaq: VYGG). Advisor at Seven1 Sports & Entertainment Agency. He is also a lecturerat the Stanford Graduate School of Business. He formerly served as business founder, vice president of business, and CFO of Dropbox from 2010 to 2015. At Dropbox, Sujay created and led the global business and finance organization. He has a Bachelor’s degree in Economics from Princeton University and an MBA from Harvard Business School.

Investment focus

Software, FinTech, Financial Services
Seed, Series B, Series A
United States, Spain, Germany

Portfolio highlights

HUBUC — A single API-platform that allows any business to embed financial services capabilities into their products.  e.g Uber can issue branded credit cards for all Uber drivers and Walmart provides customers a simple way to better manage and control their everyday finances, with no regulatory burden or compliance requirements in a few weeks.
point.me — Search and book award flights and maximize the value of your points. Travel on points for less with point.me's flight award search tool.
Fireside — Fireside is the first interactive streaming platform that invites you to be part of the show. Co-founded by Falon Fatemi and Mark Cuban the media and entertainment networks of the future are emerging on Fireside.

Before co-founding Flatiron, Nat was Co-Founder and CEO of Invite Media, an advertising technology company based in NYC. Invite Media built the industry's first enterprise advertising platform for buying and optimizing online media in real-time. Invite Media was acquired by Google in 2010. Prior to Invite Media, Nat started numerousinternet companies and also worked at Say Media and First Round Capital. An active angel investor, Nat has invested in over 30 technology startups throughout the country, including Bell Biosystems, Breakthrough, Care at Hand, DocPhin, Doctor Evidence, Genomera, Meddik, Oscar, and Predilytics. Nat earned a Bachelor of Science degree cum laude in Economics with concentrations in Entrepreneurship and Marketing from The Wharton School of the University of Pennsylvania. In his spare time, Nat is an avid golfer and tries to trick trout with fake bugs.

Investment focus

Health Care, Software, Medical
Seed, Series A, Series B
United States, China, Colombia

Portfolio highlights

CollX — Snap photos of them and instantly get the current market price. Add them to your collection and track your overall portfolio value.
Collectors — Helping collectors to pursue their passion.
Iterative Scopes — Iterative Scopes provides gastroenterologists with machine learning-powered diagnostic tools that help them prevent colon cancer and improve patient outcomes

David is Professor in the Department of Pathology, Brigham and Women’s Hospital and Wyss Institute for Biologically Inspired Engineering, and is a Howard Hughes Medical Institute Professor. David is the Scientific Founder of Illumina Inc. and Quanterix Corp and has co-founded several other life sciences startups. David has published over 300peer-reviewed papers and has over 75 issued US patents. He has received numerous national and international awards and honors for his fundamental and applied work in the field of optical microwell arrays and single molecules including the American Chemical Society Kathryn C. Hach Award for Entrepreneurial Success, Ralph Adams Award in Bioanalytical Chemistry, the American Chemical Society Gustavus John Esselen Award, Analytical Chemistry Spectrochemical Analysis Award, the Pittsburgh Analytical Chemistry Award, and the ACS National Award for Creative Invention. He is a member of the National Academy of Engineering, the National Academy of Medicine, a Fellow of the American Academy of Arts and Sciences, a Fellow of the American Institute for Medical and Biological Engineering, and a Fellow of the National Academy of Inventors. He received a BS in Chemistry from the University of Michigan and a PhD in Chemical Biology from SUNY at Stony Brook, and did postdoctoral studies at MIT.

Investment focus

Biotechnology, Genetics, Life Science
Seed, Series A, Series B
United States

Portfolio highlights

Vizgen — The next generation of genomics, expanding the impact of spatial context and demonstrating the potential of in situ single-cell spatial genomics.
Stoicheia — Mattiq delivers innovative electrochemical solutions to decarbonize the fundamental building blocks that power our world.
Torus Biosystems — Torus Biosystems offers an apparatus for DNA testing for scientific and medical research purposes in the fields of consumer products, food for human beings or animals, hygienic and beauty care for human beings or animals, agriculture, horticulture, and forestry. The company was founded in 2019 and is headquartered in Cambridge, Massachusetts.

Joshua Elkington

Investment focus

Biopharma, Life Science, Biotechnology
Seed
United States

Portfolio highlights

Tierra Biosciences, Inc. — Speed, scale and simplicity with protein synthesis on-demand. Discover your portal to thousands of custom proteins. Get testable material with a single input.
Tierra Biosciences — Speed, scale and simplicity with protein synthesis on-demand. Discover your portal to thousands of custom proteins. Get testable material with a single input.

Patrick Yang, General Partner at Amity Ventures, has led the firm’s investments in CaptivateIQ, Evisort, Flick, MoQuality, TruePill, and Vowel. He sits on the boards of Evisort and MoQuality. His primary areas of investment focus include AI, consumer, logistics, mobility, and software. Patrick co-founded Amity Ventures with CJ Reim in 2017 afterthe two worked together at Highland Capital Partners.Prior to Amity, Patrick was a Vice President at Highland, where he sourced the firm’s investment in nuTonomy, an autonomous vehicle startup acquired by Delphi one year later for $450M. Patrick is from the Bay Area and holds a B.S. in Business Administration with a concentration in Engineering Leadership from University of California, Berkeley.Pat currently serves on the board of Advancing Women in Product, a non-profit that empowers women to enter and succeed in product management roles. In his free time, he enjoys hiking and eating in the San Francisco area, and attending sporting events—especially Warriors, 49ers, and Giants games.

Investment focus

Software, E-Commerce, Health Care
Series A, Seed, Series B
United States

Portfolio highlights

Athelas — Our breakthrough technologies provide clarity on a patient's most important health metrics, all while increasing revenue for your practice.
Burrow — Meet Burrow. We make clever, uncompromising furniture and other nice things fit for modern life at home. From our comfortable, customizable sofas, sectionals, loveseats, and armchairs to our fashionable, functional rugs and tables, and five unique collections of decorative pillows and throw blankets, Burrow is the perfect place to start when shopping for your home.
Innerwell — Innerwell combines personalized guidance from licensed therapists like you with the expansive power of psychedelics to treat anxiety and depression.

Nitesh Banta is the Co-Founder & CEO at B12.

Investment focus

Software, Artificial Intelligence, Information Technology
Seed, Series A, Pre-Seed
United States, Canada, India

Portfolio highlights

Protege — Protege is the platform for AI Training Data. Protege works with data holders and model builders to empower them to share training data for AI model development.
Chai Discovery — Building frontier artificial intelligence to predict and reprogram the interactions between biochemical molecules.
Draftboard — Refer your friends, community and following with our hiring platform, and get paid when they get hired! Start referring (or hiring!) now!

Joe Betts-Lacroix is the CEO at Retro. He previously worked at OQO as a Co-Founder and CTO. Joe Betts-Lacroix attended Harvard University and Massachusetts Institute of Technology.

Investment focus

Health Care, Life Science, Biotechnology
Seed
United States

Portfolio highlights

VitaDAO — Join VitaDAO, a community owned collective funding early stage longevity research. We fund and commercialize longevity therapeutics.
Spring Discovery — Giving Scientists AI Superpowers

Patrick Collison is the Co-Founder, CEO and Content Strategist of Stripe. He previously worked at Auctomatic as a Co-Founder. Patrick Collison attended Massachusetts Institute of Technology.

Investment focus

Software, Information Technology, Financial Services
Seed, Series A, Series C
United States, United Kingdom, India

Portfolio highlights

Cortex — Cortex makes it easy for engineering organizations to gain visibility into their services and deliver high quality software.
Cursor — Cursor is an AI code editor used to enhance software engineering productivity. It offers a platform allowing developers to write code using predictive typing and natural language instructions. It also integrates with their existing codebase, ensuring privacy and security with SOC 2 certification.
Pacific Fusion — Pacific Fusion was founded in 2023 with the mission to power the world with abundant, affordable, clean energy.

Having worked in the life sciences industry for over ten years as an academic researcher, Jonathan identified the market opportunity for supplying high quality antibodies to support protein interaction studies and, in 1998, founded Abcam with David Cleevely and Professor Tony Kouzarides. Jonathan is a Non-Executive Director of Horizon DiscoveryGroup plc, The Evolution Education Trust, GeoSpock Ltd and Sydicate Room Group Ltd. He is also Chairman of Axol Bioscience Ltd, PhoreMost Ltd, Repositive Limited, Definigen Limited and Cambridge Allergy Ltd. Jonathan holds an executive director position at Meltwind Limited, being a designated member of Meltwind Advisory LLP. Jonathan is an experienced entrepreneur and investor and is passionate about supporting UK life science and high-tech start-ups. He has provided considerable investment and support to over 30 companies and has assisted three AIM IPOs.

Investment focus

Biotechnology, Health Care, Medical
Seed, Series A, Series B
United Kingdom, United States, Canada

Portfolio highlights

Clock Bio — Clock Bio operates as a biotech company, that develops novel regenerative medicines.
Shift Bioscience — Explore cutting-edge simulation-guided cell rejuvenation techniques aimed at combating aging-related diseases.
Exciting Instruments — Exciting Instruments Limited is a joint company founded in Sheffield that combines the software prowess of Bulldozer Limited with Dr. Timothy Craggs' knowledge of single molecules. Through the use of cloud connectivity and real-time data visualisation, we are a genuine science and software partnership on a mission to assist you in streamliningthe procedure for creating discoveries in biophysics, life sciences, drug discovery, and medical diagnostics.

Jay Zaveri has been serving Social Capital as a partner since November 2015. He also founded CloudOn and Future Thought Productions.

Investment focus

Biotechnology, Health Care, Artificial Intelligence
Seed, Series A, Funding Round
United States, Japan, Canada

Portfolio highlights

Cleerly — Cleerly is a healthcare company whose mission is to create digital care pathways to prevent heart attacks. The company develops a new standard for coronary artery disease by integrating quality clinical science with the latest-generation AI, in order to offer actionable clinical insights to every stakeholder in the heart care pathway.Throughthese data-driven solutions, the company aims to provide a comprehensive solution for cardiovascular disease evaluation that offers value to the healthcare system and improves heart health for patients at risk of heart attacks.
BitClout — BitClout is a platform owned by its users. Bitcoin is decentralizing money, BitClout is decentralizing social media.
Kingdom Supercultures — Kingdom Supercultures create microbial cultures that help food manufacturers to create new foods with boosted benefits. It re-assembles nature's microbes into new combinations, creating plant-based foods that taste like dairy, low-alcohol beverages with full flavor, and natural preservatives that work as well as artificial ones.They workwith clients across diverse industries including food, beverage, personal care, beauty, and more. Their technology comprises an expansive biobank of GRAS microbial strains, high-resolution strain characterization, and new algorithms for predicting and assembling microbial communities.

Craig Mundie is chief research and strategy officer of Microsoft Corp., reporting to CEO Steve Ballmer. In this role, he oversees Microsoft Research, one of the world’s largest computer-science research organizations, and is responsible for Microsoft’s long-term technology strategy. Mundie also directs a number of technology incubations, and workswith government and business leaders around the world on technology policy, regulation and standards.Mundie has spent much of his career building startups in various fields, including supercomputing, consumer electronics, education, healthcare and robotics. He joined Microsoft in 1992 to create and run the Consumer Platforms Division, which developed non-PC platforms such as the Windows CE operating system; software for the Handheld PC, Pocket PC and Auto PC; and early console-gaming products. Mundie also started Microsoft’s digital-TV efforts, acquiring and managing its WebTV Networks subsidiary, and built its fast-growing healthcare solutions business.Prior to his current role, Mundie served as Microsoft’s chief technical officer for advanced strategies and policy, working with Microsoft Chairman Bill Gates to develop the company’s global strategies around technical, business and policy issues. Another long-standing focus for Mundie is privacy, security and cyber-security. He initiated Microsoft’s Trustworthy Computing initiative, which has leveraged new software-development practices to significantly improve the security of the company’s products.For more than a decade, Mundie has also been Microsoft’s principal technology-policy liaison to the U.S. and foreign governments, with an emphasis on China, India and Russia. He has served on the U.S. National Security Telecommunications Advisory Committee and the Markle Foundation Task Force on National Security in the Information Age. In April 2009 Mundie was appointed by President Barack Obama to the President’s Council of Advisors on Science and Technology.Mundie started his career in 1970, working on operating-system development for the Data General NOVA at Systems Equipment Corp. (SEC) while still studying at Georgia Tech. SEC was subsequently acquired by Data General Corp., where Mundie went on to develop the INFOS data-management system. In 1977 Mundie moved to Data General’s advanced development facility in Research Triangle Park, N.C., ultimately becoming its director. In 1982, Mundie was one of three co-founders of Alliant Computer Systems Corp., which developed vector-parallel mini-supercomputers. He held a variety of positions at Alliant before becoming CEO. The company shut down in 1992.Mundie holds a bachelor’s degree in electrical engineering and a master’s degree in information theory and computer science from Georgia Tech. Mundie enjoys traveling and spending time on his boat. He is married, with one married daughter.

Investment focus

Life Science, Chemical, Genetics
Seed, Series B, Series C
United States

Portfolio highlights

Stoicheia — Mattiq delivers innovative electrochemical solutions to decarbonize the fundamental building blocks that power our world.
Exicure — Exicure is Formerly Known as AuraSense Therapeuticsis. Exicure is developing a new class of immunomodulatory and gene silencing drugs against validated targets. Our 3-dimensional, spherical nucleic acid (SNA™) architecture unlocks the potential of nucleic acid therapeutics in multiple organs. Our lead programs address diseases from inflammatorydisorders to oncology.SNA constructs overcome one of the most difficult obstacles to nucleic acid therapeutics: safe and effective delivery into cells and tissues. SNA constructs exhibit unparalleled transfection efficiency into numerous cell and tissue types including the skin without carriers or transfection agents. Moreover, SNAs can be used as potent immunotherapeutic agents for the treatment of cancer or infectious disease.

Peter Harris

Investment focus

Life Science, Biotechnology, Health Diagnostics
Seed
United States

Portfolio highlights

CND Life Sciences — Our suite of neurodiagnostic tests give clinicians access to objective pathological insights on diseases that are often difficult to diagnose

Mei is an early stage investor focused on AI. Mei studied at MIT and the MIT Media Lab

Investment focus

Software, Artificial Intelligence, Biotechnology
Seed, Series A, Pre-Seed
United States, United Kingdom, Singapore

Portfolio highlights

Coframe — Transform your website with AI-driven optimization and personalization that boosts engagement and conversions. Coframe automates growth 24/7.
Exa — Exa is an AI research center that is reinventing the quest for AI.
The San Francisco Compute Company — The San Francisco Compute Company manufactures supercomputers.

Considered one of the fathers of science & technology strategic communications - founded Technology Solutions, Inc. in 1983. Client list read like a who's who list of startup technology companies in computing, communication, software, education, and entertainment. Maintained a strategic communications partnership with Sony & IBMCorporation (10 years). Received the Gold CIPRA award in 1998 for the IBM Deep Blue/Gary Kasparov Chess Match. In 1996, TSI was recognized as the #1 fastest growing agency in the United States. Sold the company to The McCann Erickson World Group in 1997 and became the Vice Chairman. Created Focus Technology, an organization that provided qualitative research and instituted the RPM model of integrated strategic communications providing ultra-competitive technology clients the ability to quickly discover and leverage their key strengths as well as mitigate their destructive weaknesses.Brian was a pioneer in the founding of a number of the first computing publications including Computer Systems News and InformationWeek magazine. Now serves as Chairman of the New York Angels. He is very devoted to the New York City startup community.Developed the AIMS (Applied Internet Media Studies) Program, a senior/graduate level college semester program where students will be rigorously trained to use the internet professionally.Frequent speaker on strategic communication, entrepreneurism and early startup investing. Now writing a book for McGraw Hill - a new organizational product launch model.Received the Distinguished Alumnus Award, holds a Masters Degree in Science Communications from Boston University's School of Communications.

Investment focus

Software, SaaS, Mobile
Seed, Series A, Funding Round
United States, Israel

Portfolio highlights

Authorea — Authorea is a provider of a collaborative platform that is designed to read, write, discuss, and publish research. Its platform serves as a powerful document editor for researchers and provides collaborative editing, automatic citation formatting, tracking changes and it has the ability to make any document public or fully private that enablesresearchers to write documents together and attach references, figures, data, and source code. It improves how researchers work and make breakthrough discoveries by tackling one of the most important parts of the research cycle which is communication.
CourseHorse — CourseHorse is a provider of a learning platform used to centralize the learning opportunities. Its platform partners with providers of Spanish lessons, cooking courses, yoga classes, and other classes to create a single destination for people seeking personal interest education that enables people to increase ease and confidence in discovering thepath to personal enrichment.It was founded in 2011 and is headquartered in New York.
Boundless Mind — Thrive Global's mission is to end the burnout epidemic with sustainable, science-based solutions that unlock employee performance and enhance well-being through our behavior change technology.

Michael Chambers is the Co-Founder at Agathos Biologics.Michael’s vision and leadership of Aldevron has resulted in several milestones including the 2004 acquisition of Genovac Antibody Technology of Freiburg, Germany; the 2009 expansion of protein production in Madison, Wisconsin; private equity transactions by TA Associates in 2017 and EQT in2020; and the purchase of Aldevron by Danaher for $9.6 billion in 2021. Michael is committed to ethical pharmaceutical development and his leadership will enable Agathos to create new paradigms in biotechnology to achieve these goals. Michael received Bachelor of Science degrees in biotechnology, chemistry, and microbiology from North Dakota State University.

Investment focus

Biotechnology, Genetics, Life Science
Series A, Funding Round
United States

Portfolio highlights

Kytopen — Kytopen is pioneering a novel and non-viral process to engineer human cells for therapeutic applications in immuno-oncology and genetic disorders.
Erbi Biosystems — Erbi Biosystems is a transformative microfluidic bioprocess instrumentation company.
64x Bio — 64x Bio builds a platform that increases the speed and scale of mammalian cell line discovery.The company uses a throughput discovery and screening platform and an integrated computational design loop, they develop new ways of generating highly optimized and otherwise unattainable cell lines for the manufacturing of viral vectors, with a specificfocus on those used for cell and gene therapies.

Before co-founding Flatiron, Zach was Co-Founder, President and COO of Invite Media, an advertising technology company based in NYC. Invite Media built the industry's first enterprise advertising platform for buying and optimizing online media in real-time. Invite Media was acquired by Google in 2010. Prior to Invite Media, Zach co-foundedEatNow.com which was privately acquired. An active angel investor, Zach has invested in over 30 technology startups throughout the country, including Bell Biosystems, Breakthrough.com, Care at Hand, DocPhin, Doctor Evidence, Genomera, Meddik, Oscar, and Predilytics. Zach studied economics and entrepreneurship at The Wharton School at the University of Pennsylvania.

Investment focus

Health Care, Software, SaaS
Seed, Series A, Pre-Seed
United States, Israel, United Kingdom

Portfolio highlights

Scoop — Thrive in a hybrid work environment with Scoop's solutions for Workplace Safety, Workplace Utilization, Team Coordination, Desk Management, and Commute.
Iterative Scopes — Iterative Scopes provides gastroenterologists with machine learning-powered diagnostic tools that help them prevent colon cancer and improve patient outcomes
Overwatch Research — Generate accurate in vivo study data as a part of your efficient, connected R&D.

Elad Gil is the Co-Founder of Color Genomics. He previously worked at Twitter as a Vice President. Elad Gil attended the Massachusetts Institute of Technology.

Investment focus

Software, Information Technology, Artificial Intelligence
Seed, Series A, Series B
United States, United Kingdom, Israel

Portfolio highlights

Socket — Socket fights vulnerabilities and provides visibility, defense-in-depth, and proactive supply chain protection for JavaScript, Python, and Go dependencies.
Decagon — Trusted by world-class companies, Decagon is the most advanced AI platform for customer support.
Braintrust Data — The end-to-end platform for building world-class AI products

Lars Fjeldsoe-Nielsen is a Co-Founder & serves as a Partner at 2xN. Lars Fjeldsoe-Nielsen was General Partner at Balderton Capital in London from 2015-2021 through four funds. He joined after spending a decade in Silicon Valley where he was with Uber and Dropbox.Since 2012 his venture track record includes two IPOs (Uber, Dropbox) and 11acquisitions.Lars joined Balderton from Uber which he joined when the company was operating in less than 20 cities. His role as Vice-President resulted in strategic alliances. Lars joined Uber from Dropbox as one of the company’s first 25 employees. As Head of Mobile, his growth deals with Samsung and other mobile OEMs helped Dropbox reach its first 100 million users. Prior to that Lars held positions at Voicesignal (acq. Nuance), Skyhook Wireless (acq. TruePosition), Ness Technologies (acq. Opentable), 3Jam (acq. Skype) and T9 Tegic (acq. AOL). More than a billion people have used the software and services distributed as a result of mobile growth partnerships led by Lars.His venture investments include Voi (Raine), Labster (A16Z), Hiya (Ericsson), Cambridge Quantum Computing (HON), Hopin (A16Z), Opensea (A16Z), Yassir (YC), Beacon (Eric Schmidt), The org (Sequoia), Octant (A16Z), Zycada (Khosla), Monarch Money (Accel) and Kukua (Tencent), Dubsmash (acq. Reddit), Tempow (acq. Google), Rahko (acq. Odyssey Therapeutics), Pocket (acq. Mozilla), Blue Bottle (acq. Nestle), Marble (acq. Caterpillar).Lars, who is Danish-Portuguese, grew up across Africa and served with the Royal Danish Guards. He holds a MBA from London Business School, where he also serves on the Board of Trustees, an MSc from Oxford University Keble College and a BSc from King’s College, London. He lives in London with his wife and three children.

Investment focus

Software, Information Technology, Mobile Apps
Seed, Series A, Funding Round
United States, Denmark, United Kingdom

Portfolio highlights

HUBUC — A single API-platform that allows any business to embed financial services capabilities into their products.  e.g Uber can issue branded credit cards for all Uber drivers and Walmart provides customers a simple way to better manage and control their everyday finances, with no regulatory burden or compliance requirements in a few weeks.
LiveFlow — The easiest way to bring financial data into your spreadsheet. Automate your finances, consolidate your accounts and collaborate in real-time. Try LiveFlow for free today!
Quantrol Ox — Building Machine Learning Based Software for Quantum Control with a goal to maximise quantum computer uptime.

Balaji S. Srinivasan is the Co-Founder and Board Member of Coin Center. He was the CTO of Coinbase and cofounder of Counsyl, Earn, Teleport, and Coin Center. He was previously CEO at Earn.com, which was recently sold to Coinbase. Prior to taking the CEO role at Earn.com, Dr. Srinivasan was a General Partner at Andreessen Horowitz. Prior to joininga16z, he was the co-founder and CTO of Founders Fund-backed Counsyl, where he won the Wall Street Journal Innovation Award for Medicine and was named to the MIT TR35. Dr. Srinivasan holds a BS, MS, and PhD in Electrical Engineering and an MS in Chemical Engineering from Stanford University. He also teaches the occasional class at Stanford, including an online MOOC in 2013 which reached 250,000+ students worldwide.

Investment focus

Blockchain, Cryptocurrency, Software
Seed, Pre-Seed, Series A
United States, India, Singapore

Portfolio highlights

The Arena — Arena. social is a cutting-edge SocialFi platform that is revolutionizing how content producers interact, network, and make money from their work.
Lica World — Hire Lica, AI Video Producer for Product, Sales, And Customer Success Teams
OpenGradient — OpenGradient is a leading decentralized AI platform for open-source model hosting, secure inference, agentic reasoning, and application deployment. By developing tooling and a feature-rich platform that makes developing AI workflows both secure and seamless, OpenGradient empowers developers with the ability to build in its ecosystem of intelligentand optimized AI-empowered applications. With native model hosting, permissionless composability, and secure inference execution, OpenGradient also aims to accelerate open-source AI by democratizing model ownership, improving verifiability guarantees, and promoting censorship-resistant model access.Our heterogeneous AI compute architecture (HACA) and our proprietary library NeuroML scale secure AI workflows with features like inference, agentic reasoning, statistical analysis, and more. OpenGradient also accelerates open-source innovation with a web portal and SDK for Web2 developers to leverage our AI stack without navigating blockchain complexities, while enjoying the security and composability benefits of decentralized infrastructure.

CJ Reim is a co-founder of Amity Ventures and an active investor in Avochato, Carta, Ouster, Talkdesk, and more than 15 other growing technology businesses. CJ is currently focused on investments in software, fintech, and consumer sectors, and represents Amity on the boards of Avochato and MaintainX.Prior to Amity, CJ was a Vice President on theinvestment team at Highland Capital Partners, where he focused on technology investments across all stages of company growth. He also led the Summer@Highland entrepreneurship program which, over its nine-year history, has mentored 50 student-led startups from inception. CJ is originally from Minnesota and holds a B.S. in Management with concentrations in Finance and Information Systems from Boston College. Outside of Amity, CJ enjoys CrossFit, freediving, and downhill skiing.

Investment focus

E-Commerce, Robotics, Software
Series A, Seed, Pre-Seed
United States

Portfolio highlights

Athelas — Our breakthrough technologies provide clarity on a patient's most important health metrics, all while increasing revenue for your practice.
Burrow — Meet Burrow. We make clever, uncompromising furniture and other nice things fit for modern life at home. From our comfortable, customizable sofas, sectionals, loveseats, and armchairs to our fashionable, functional rugs and tables, and five unique collections of decorative pillows and throw blankets, Burrow is the perfect place to start when shopping for your home.
Arkive — Arkive is a web3 museum of real world items, curated by a community of passionate hobbyists, collectors, artists, designers, and creators.

Kevin Patrick Mahaffey is the Founder of Lookout and SNR. He is also the Executive Chairman of Stork Club and an Investor.

Investment focus

Software, SaaS, Enterprise Software
Seed, Series A, Pre-Seed
United States, Canada, Israel

Portfolio highlights

Karman+ — Mining near Earth asteroids
bem — Engineering teams use bem to transform any data point into whatever shape they need.
Resquared — Resquared has everything you need and more to reach local businesses. Contact data on every local business, optimized email and social outreach tools, and step-by-step built-in playbooks.

Jim Greer is the Chief Executive Officer at Bash. He was the co-founder and Chief Executive Officer of Kongregate. Before founding Kongregate in June 2006, Jim was Technical Director for Pogo at Electronic Arts. He has worked in the game industry since 1991.

Investment focus

Health Care, Life Science, Biotechnology
Seed
United States

Portfolio highlights

Vium — Vium is a biotechnology company that develops digital biomarkers to transform preclinical research and animal welfare. It is fully accredited by AAALAC International and received an unprecedented AAALAC commendation for upholding the 3 Rs, the gold-standard framework for humane animal research. Customers run the spectrum of biotechnology,pharmaceutical, and computational drug discovery companies to academia and novel therapeutic labs.Vium's digital platform provides physiological biomarkers that enable better decisions on which compounds should be advanced to the clinic. The company's platform Digital Vivariumand Vium Cloud is the gold-standard in vivo platform combining computer vision, artificial intelligence, machine learning, and sensor technology to non-invasively collect and derive insights from digital biomarkers. The platform continuously captures physiological metrics and behaviors non-invasively, providing more sensitive and accurate data collection, leading to more replicable studies.Vium was founded in 2013 and is headquartered in San Mateo, California, United States.

Jeff Raikes is the Co-founder of the Raikes Foundation.

Investment focus

Video, AgTech, Sports
Series A, Series C, Series D
United States

Portfolio highlights

Hudl — Hudl provides video review and performance analysis tools for sports teams and athletes at every level.
Epicrop Technologies — The only company using a nature-based epigenetic approach to enhance crops, accelerating development and delivering proven results.

Over the course of the last decade, first as a graduate student at Harvard University in the Department of Molecular and Cell Biology with PhD advisor Professor Stuart Schreiber and then as an independent postdoctoral fellow at the Lewis-Sigler Institute at Princeton University, Dr. Ethan Perlstein developed an approach to studying old drugs anddiscovering new drugs in model organisms called evolutionary pharmacology. Ethan is an author on 19 peer-reviewed scholarly publications, including the discovery of a novel mechanism of action for the antidepressant Zoloft based on studies in yeast cells.

Investment focus

Biotechnology, Cannabis, Biopharma
Seed
United States, Canada

Portfolio highlights

Epinoma — Epinoma is a diagnostics company that focuses on the multi-omics approach to cancer monitoring. It engineers proteins that control the operating system of biology. The company was founded in 2020 and is headquartered in San Francisco, California.
BluumBio — BluumBio develops next-generation remediation technologies that clean up pollution and restore degraded ecosystems
Promakhos Therapeutics — A Boston-based biotech startup developing therapeutics.

Lu, the founder of Biosensors International Group Ltd, was its chairman and CEO from its inception to 2008. He retained his leadership position as chairman of the Group since January 2008. Today BIG is one of the leading medical device companies with a market cap in excess of $1.6B.

Investment focus

Medical, Health Care, Artificial Intelligence
Seed, Series A
United States

Portfolio highlights

Bot MD — Bot MD Care is an A.I. clinical chat assistant. Our A.I. integrates hospital information to provide instant answers to doctor queries and helps automates patient monitoring.
BioTrillion — We so often think of Healthcare as an industry, that we tend to forget about Healthcare as a purpose. Globally and annually, trillions of dollars are ineffectively spent on healthcare and trillions of life data points are ineffectively connected to insights about our health. There is a better way.BioTrillion is a little startup with boldambitions to more efficatiously and scalably advance Healthcare – via Digital Biomarkers.Every human generates massive amounts of life data that will unlock novel health insights & applications. BioTrillion is developing a mobile health technology platform called BioEngine4D™ – for digitally detecting dangeous drugs, digitally detecting developing diseases, and data driven drug development – by measuring data from life, analyzing it through computational advancements in machine learning and artificial intelligence, and applying it back for life.BioTrillion, Inc. is headquartered in San Francisco, CA and is reimagining Life Sciences through the fundamental principles of many sciences.Our mission is to enable consumer smart devices to empower ordinary consumers with extraordinary health insights. Advances in technology have amplified our individual capabilities in many ways, and healthcare should be no exception.Website: www.biotrillion.com Contact: contact@biotrillion.com Jobs: https://www.biotrillion.com/opportunities Application: https://biotrillion.typeform.com/to/wSvoKI

Don Mattrick is Chief Executive Officer of Zynga, a social game services company headquartered in San Francisco, California. His mandate is to further the company’s mission of connecting the world through games. As an industry-leading executive in entertainment, games, and consumer products, Mattrick has firmly established himself during a 30-yearcareer as a world-class leader of game, platform, and team development.Before joining Zynga in 2013, Mattrick, 49, spent six years at Microsoft – the last three as President of the Interactive Entertainment Business. He was responsible for leading the team that grew Microsoft’s Xbox 360 global installed base by 700 percent, to nearly 75 million consoles, and Xbox Live membership from 6 million to nearly 50 million subscribers in 41 countries. During his tenure at Microsoft, Mattrick also oversaw businesses and services focused on consumer products, including PC and mobile interactive entertainment and the groundbreaking Kinect entertainment products; the Kinect was released in November 2010 and set a Guinness World Record for the fastest-selling consumer electronic device in its first 60 days. Mattrick is widely recognized for transforming the Microsoft Interactive Entertainment Business from one that was operating at a loss into a sustained and profitable business.Prior to Microsoft, Mattrick served in several leadership positions at Electronic Arts, most recently as President of Worldwide Studios, in which capacity he oversaw EA's global studios and research & development in several major sites, including Redwood Shores, Calif. (Silicon Valley), Los Angeles, EA Tiburon in Florida, EA Canada in Vancouver, British Columbia, and Montreal, and EA U.K. During his 15-year career at Electronic Arts, Mattrick helped develop and scale the company’s leading global game franchises and brands, including Need for Speed, FIFA, and The Sims.Mattrick founded his first company, Distinctive Software, at age 17; it was acquired by Electronic Arts in 1991 and subsequently became EA Canada.Over the years, Mattrick has been broadly recognized for his work in the technology industry. In 2011, he was featured in Fortune Magazine as one of the "Smartest People in Tech,” highlighting his leadership in growing the Xbox business, including the pivotal role he played in driving new consumer innovations such as Kinect; and in May 2012, he was named one of CNN Money’s top 10 “brilliant technology visionaries.”Raised in Vancouver, British Columbia, Mattrick is married with two children. In acknowledgement of his role in building the interactive entertainment business in Canada and the active development of industry links with the University of British Columbia, Mattrick received the UBC Award as an Honorary Fellow from the Sauder School of Business and was awarded the highest honor Simon Fraser University can bestow, the Doctor of Laws. He has served on several public and private boards, including the advisory board for USC School of Cinematic Arts.

Investment focus

SaaS, Life Science, Non-Fungible Token (NFT)
Series B, Seed, Series A
Canada, United States

Portfolio highlights

Dapper Labs — Dapper Labs uses the power of play to deliver blockchain-based experiences that are made for you and ready for the real world.
Mino Games — Mino Games is a free-to-play mobile gaming studio that produced the top 50 grossing mobile game Mino Monsters, with over 13 million downloads. We create deeply engaging, widely appealing games for millions of fans. We’re currently building our world class development studio in Montreal.We are a small group of passionate engineers, artists andanalysts with a mission to create games that millions of people all around the world love to play for years. We are funded by the best angel investors, institutional investors, and gaming companies from across the world.Our third and latest game, Cat Game, has already hit the App Store’s Top 100 Grossing Chart in Canada. The game, currently in soft launch, is showing world class key metrics, and we are expecting it to be a global hit when we launch it by February 2019.We are looking today to grow the team and looking for world class ambitious talent to come join us on the journey, to develop and support this newest title into a global success on both iOS and Android, and help us with future projects as we rapidly grow.
Epicrop Technologies — The only company using a nature-based epigenetic approach to enhance crops, accelerating development and delivering proven results.

Evan Cheng Co-founder & CEO at Mysten Labs. He attended Syracuse University.

Investment focus

Software, Artificial Intelligence, Biotechnology
Seed, Pre-Seed, Funding Round
United States, United Kingdom, Australia

Portfolio highlights

PARSIQ — Explore the future of blockchain with PARSIQ - Your gateway to advanced blockchain monitoring, smart triggers, and real-time intelligence. Empower your crypto journey with cutting-edge technology and unparalleled insights. Join us in revolutionizing the way you interact with the blockchain ecosystem
PIN AI — PIN AI democratizes personal on-device intelligence for everyone; transform your digital footprints into your Personal Executive Assistant.
Verida — The Verida Wallet is a mobile application that allows you to manage your decentralized identity and personal data. It provides a user-friendly interface for interacting with applications built on the Verida network.

Domenic Merenda is the Head of Science and Engineering for Sponsored Display Non-Endemic at Amazon.

Investment focus

B2B, Sales, Gaming
Seed, Angel, Funding Round
United States

Portfolio highlights

Ceqoo — Ceqoo provides the training-wheels, process rigor, and performance measurement to help sales teams succeed without replacing the existing tools in the sales process or requiring more work.
Win-Win — Win-Win is a gamified giving platform that offers fantasy sports-style tournaments hosted by NFL and NBA athletes. Each tournament features a charitable cause chosen by host athletes and when fans join the tournament they make a voluntary, tax-deductible donation to the cause. It combines giving gaming to make donating to charity more fun andengaging for all.Win-Win was founded by former NFL linebacker and Duke University All-American, Mike T. Brown in 2016 and is headquartered in Oakland, California, United States.
BotFactory — BotFactory sells desktop enterprise 3D printing solutions using inkjet nanotechnology, computer vision, and artificial intelligence to fabricate complete electronic boards in a few hours, greatly accelerating our customers' time to market.Applications are diverse, including flexible electronics, e-textiles, drone tech, IoT, distributedmanufacturing, and professional R&D services.

Norman Sorensen who is a Class II director, joined the Board of Directors in March 2015. He is a member of the Company’s Finance, Risk Management and Audit Committee. Mr. Sorensen formerly served as chairman of the International Insurance Society, Inc., a professional organization for the insurance industry, from January 2010 until June 2013. Mr.Sorensen has served as a director of the International Insurance Society, Inc. since January 2005. Previously, from November 2011 until December 2012, he was chairman of the International Advisory Council of Principal Financial Group, Inc., a global financial investment management company. He was chairman of Principal International, Inc., serving from June 2011 to October 2012, and president and CEO of International Asset Management and Accumulation of Principal International, Inc., serving from January 2001 to June 2011. Mr. Sorensen has served as a director of Encore Capital Group, Inc., a consumer banking company, since November 2011. Mr. Sorensen also served as a director of Sara Lee Corporation, an American consumer-goods company, from January 2007 to November 2011. He has served as executive vice president of both Principal Financial Group Inc. and Principal Life Insurance Company, a life insurance company, since January 2007, and held a number of other senior management positions since 1998. Mr. Sorensen also served as chairman of the U.S. Coalition of Service Industries, a leading forum for the services sector, from January 2003 to March 2005. Mr. Sorensen served as a senior executive of American International Group, Inc., an insurance services company, from September 1989 to December 1998. He also formerly served as chairman and director of DE Master Blenders, from December 2011 until September 2013.

Investment focus

SaaS, FinTech, Analytics
Seed
United States

Portfolio highlights

Solidus Labs — The first automated, comprehensive and testable market surveillance and risk monitoring hub tailored for digital assets
Thrive Bioscience — Thrive Bioscience is commercializing a family of instruments and software that provide imaging, analytics, and automation to significantly improve cell culture and the analysis of live cells. Thrive’s instruments empower biologists to deliver consistent, reproducible results by leveraging microscopy, robotics, fluidics, and other fields, to captureimages and data and provide analysis, reports, guidance, documentation, and a database on the cells and on cell culture processes.

Scott Garber is the Managing Partner of Early Light Ventures. He attended The George Washington University School of Business.

Investment focus

Software, Information Technology, Cyber Security
Seed, Pre-Seed, Series A
United States

Portfolio highlights

Ethix360 — ETHIX360 provides Compliance as a Service (CaaS); a simple, affordable answer to employee ethics communication and human resources case management.
Ash & Erie — Men's clothes designed from scratch for shorter men 5'8" and under. Find men's casual and formal clothing from button-downs, t-shirts, sweaters, denim jeans, chinos, and more. FREE Shipping, Exchanges, and Returns.
Outlogic — Outlogic is a provider of location data for the retail, real estate, and financial markets. Outlogic has exemplified high standards and best practices for the collection and use of location data while still allowing companies to develop disruptive tools built on a foundation of quality data.

Dr. Ling Wong is Founder and General Partner of Highbury Group and Sea Lane Ventures. She also serves as Senior Advisor to Lightspeed Venture Partners. Highbury Group was founded on the principle to be a true partner and champion to entrepreneurs, using science and technology to build companies that fundamentally transform the world for thebetterment of humanity today, and in the future.Dr. Wong draws from her unique background and experience as a scientist, entrepreneur, and investor to support and bring to market companies that exist at the intersection between health and technology. “I love to partner with mission-oriented founders working on transformational ideas that can have a positive, lasting impact on society – and do so by leveraging technology and science in a financially sustainable manner,” said Dr. Wong.Prior to Highbury, she served at the Gates Foundation where she helped to establish a $1.5B global investment portfolio and created a $200M early stage program to support early stage entrepreneurs in more than 60 countries.As a health and technology investor, Dr. Wong has been involved in some of the market’s most significant investments and exits. She has partnered with over fifteen $1B+ companies, including: Devoted Health, Orca Bio, Collective Health, Color, Apeel, Shape, Stripe, Offer Up, Rappi, Branch Metrics, Notion, Modern Animal, Wheel and Satellite Bio. Notable exits include: Anacor Pharmaceuticals (acquired by Pfizer for $5.2B), Genocea Biosciences (NASDAQ: GNCA), Visterra (acquired for $430M), Slack (NYSE: WORK), Guardant Health (NASDAQ: GH), and recently Singular Genomics (NASDAQ: OMIC).Dr. Wong holds a PhD from Harvard in Engineering Sciences, a BSc in Chemical Engineering and BSc in Biology from MIT. During her time at Harvard, she created the world’s first inhaled TB vaccine. Her scientific training has shaped how she assesses financial opportunities, both to create value and to benefit human health. Dr. Wong has always been passionate about seeking entrepreneurs and partners that are looking to disrupt the status quo in science and technology for the betterment of society.

Investment focus

Biotechnology, Health Care, Medical
Series A, Series B, Series C
United States, Colombia

Portfolio highlights

Satellite Bio — Satellite Bio specializes in cell therapy, regenerative medicine, synthetic biology, cell biology, and tissue engineering. It focuses on the development and implementation of proprietary, off-the-shelf, implantable satellite organs as living therapeutic solutions that can transform the lives of millions of patients who suffer from serious diseases.
Devoted Health — Devoted Health is a new healthcare company serving seniors. Aiming to launch Medicare Advantage plans in 2019, their mission is to build a healthcare solution good enough for Mom. They will be devoted to the health and wellness of their members by helping them navigate the health care system with personal guides, by utilizing world-class technologyto enable a simplified experience, and by partnering with top providers for better health outcomes.
Shape Therapeutics — Shape Therapeutics (ShapeTX) is a biotechnology company with an end-to-end approach to RNA Gene Therapy, potentially enabling the development of cures in neurodegenerative, metabolic and rare genetic diseases through our breakthrough payload, delivery, and manufacturing platform technologies. Our vision is to facilitate adoption of thesetechnologies throughout the industry to develop effective treatments for as many patients as possible.

Chloe Sladden - Founding Partner @ #Angels

Investment focus

Software, Health Care, Mobile Apps
Seed, Series A, Convertible Note
United States

Portfolio highlights

Digits — Ready in seconds. No setup required.
Threads — Founded in 2017, Threads is a San Francisco-based company designed to help teams inform, discuss, and make decisions at scale. For leaders at every level of a company, Threads is a platform for work that best delivers on decision making by tapping into the collective wisdom of an entire team, providing everyone with a voice to assure betterbusiness outcomes. Join the future of work and learn more at threads.com or follow us on Twitter @threads.
Clubhouse — Clubhouse is an internet company.

Wes Osbourn

Investment focus

Chemical, Life Science, Biotechnology
Pre-Seed
United States

Portfolio highlights

Capra Biosciences — We use biology to make high performance renewable chemicals affordable and sustainable. We are revolutionizing chemical production with our patented bioreactor technology.

Jude Gomila is currently CEO and Founder of the startup Golden.

Investment focus

Software, Biotechnology, Information Technology
Seed, Pre-Seed, Angel
United States, United Kingdom, Canada

Portfolio highlights

Parcha AI — Parcha is an AI-powered enterprise software that enables businesses to automate their scale compliance and operations.
HockeyStack — HockeyStack enables marketing teams to drive pipeline efficiently and sales teams to close deals faster with modern attribution, holistic buyer journeys, and account insights.
Farmako — Install Farmako app, get a free health ID and get all your medical records safe and secure in one place!

Ali Shaaban has been a pioneer in the digital advertising and communications industry for more than 18 years, founding the award-winning full-fledged creative digital agency Icon Creations back in 2003 when the industry was at its infancy stage. Since then, Ali Shaaban has built strong long-term relationships and a strategic network with most ofthe leading automotive brands in Egypt and the Middle East, where he established a solid track record of delivering top-notch digital products & services that stood the test of time. Driven by passion for excellence and an always-on personalized approach to satisfying his partners, Ali Shaaban is the quintessential digital partner to have on your side in the automotive industry today.His automotive portfolio includes Alfa Romeo, Bentley, BMW, Castrol, Citroën, Ferrari, Fiat, Ford, Hyundai, JAC, Jaguar, Jeep, KIA, Land Rover, Maserati, Mazda, MINI, Mitsubishi, Nissan, Peugeot, Pirelli, Renault, Seat, Subaru, Toyota, Volkswagen and more. Aside from being a digital pioneer, Ali Shaaban is also an angel investor and serial supporter of emerging innovative startups and fresh business ideas, venturing into several sectors to contribute in making a sustainable impact on the local and regional economies. His latest investments have tapped into the Fintech sector with rising companies such as Paynas (https://Paynas.com), Oxygen (https://oxygen.us/), Dfin Holding (https://www.dfinholding.com/) , and Kiwe wallet (https://kiweapp.com/) as well as the Media and AI sector with Speakol (https://speakol.com/) , NU Digital Awards (https://nudigitalawards.com/) and Nanotronics (https://nanotronics.co/ ).Ali Shaaban believes in always taking the next step forward in his extensive career, and using his core values and commanding personality as motivation, he has paved an impressive path over the years that will certainly lead towards an even more diverse and fruitful future.

Investment focus

Financial Services, FinTech, Banking
Series A, Seed, Pre-Seed
Egypt, United States, Kenya

Portfolio highlights

ImaliPay — ImaliPay is a financial health platform offering financial products to freelancers and blue collar gig workers in partnership with gig platforms.
QuadriBot — QuadriBot is an engineering company specializing in the design and development of electronics and automation technology, real-time systems and the development of IT and electronic solutions around smart transportation issues. We focus on robotics and autonomous vehicles as well as any mobile platfo.
Nanotronics Imaging — At Nanotronics we provide customized solutions for automated optical inspection, process control, and security. Learn more about what we can do for you.

Daniel Goldman Managing Partner of Ignition Angels/Keystone CatalystsA pioneer in online gaming and online communities, Daniel has a passion for applying technology to real world problems. He studied cognitive neuroscience at Columbia and became COO and VP PD at Posit Science, with Dr. Michael Merzenich, the world leading expert onneuroplasticity. There he incorporated the latest understanding of reward systems, neuroplasticity and the science of play into products for cognitive rehabilitation. Currently an angel investor, Daniel’s interest is for a world where everyone has ubiquitous access to opportunity, both social and economic, as well as freedom of thought.

Investment focus

Chemical, Biotechnology, Video
Seed, Series A, Convertible Note
United States, United Kingdom

Portfolio highlights

Chai — Chai allows anyone to detect anything, anywhere with DNA, transforming biotech into an everyday productivity tool. Chai's Real-Time PCR and qPCR instruments are as accurate as a lab test, but cost 10x less, and are easy enough for anyone to use. Chai also develops PCR Master Mixes for the detection any pathogen, bacteria, virus, allergen,gene, species, or DNA tracer on-site at the point of need.Chai is impacting large industries such as food, agriculture, research, education, and security, while providing new solutions to combat consumer fraud, protect the environment, improve global health, and make small businesses like microbrewers more profitable.
Grit Media — Grit is a sports media start-up creating original digital videos for Gen Z.
Advanced Ionics — Advanced Ionics has created an electrolyzer that allows industrial hydrogen users to produce green hydrogen for less than $1/kg.

Elliott Sigal, M.D., Ph.D. joined NEA as a Venture Partner and Senior Advisor in 2014. He is a former Executive Vice President and Director of Bristol-Myers Squibb, and served as Chief Scientific Officer and President of R&D for Bristol-Myers Squibb from 2004 until 2013. He was a principal architect of the successful Biopharma TransformationStrategy of the company. He has been instrumental in increasing R&D productivity, developing the company’s strategy in biologics and acquiring external innovation in Bristol’s String of Pearls initiative. Under his leadership, fourteen new medicines have come to market including Abilify (Schizophrenia, Bipolar Disorder), Reyataz (HIV/AIDS), Erbitux (Colon Cancer), Baraclude (Hepatitis B), Orencia (Rheumatoid Arthritis), Sprycel (Leukemia), Atripla (HIV/AIDS), Ixempra (Breast Cancer), Onglyza and Kombiglyze (Diabetes), Nulojix (Transplantation), Eliquis (Anticoagulant), Yervoy (Melanoma), and Forxiga (Diabetes). Among his accomplishments in various therapeutic areas was building BMS research into a lead position in the promising area of immuno-oncology. In 2012, Dr. Sigal was named the best R&D chief in the pharmaceutical industry by Scrip Intelligence.Dr. Sigal currently serves as a senior advisor to the healthcare team of New Enterprise Associates and also consults for select biotechnology companies. Dr. Sigal received his M.D. from the University of Chicago in 1981 and trained in Internal Medicine and Pulmonary Medicine at the University of California, San Francisco (UCSF). Prior to medical school he studied engineering at Purdue University, where he received a B.S., M.S., and Ph.D. Dr. Sigal serves as a member of the Board of Directors for the Mead Johnson Nutrition Company and the Melanoma Research Alliance.

Investment focus

Health Care, Biotechnology, Medical
Series A, Series B
United States

Portfolio highlights

Surface Oncology — Surface Oncology is developing next generation immunotherapies that target the immune-suppressive tumor microenvironment to attack cancer.
Mersana Therapeutics — Mersana Therapeutics employs its biodegradable polymer platform to create new and better medicines. They are advancing their own clinical-stage pipeline of novel compounds with the potential to address multiple oncology indications. It was founded in 2005 and headquartered in Cambridge, Massachusetts.

Joe Beverly

Investment focus

Marketing, Advertising, Life Science
Pre-Seed, Series A
United States

Portfolio highlights

MooveGuru — MooveGuru helps real estate agents and brokerages maintain relationships with clients from this move to the next.
Lena Biosciences — Lena Biosciences 3D cell culture products and services

Zen Chu believes that now is the best time in history for healthcare entrepreneurs and engineers to create the data, systems and products to help medicine scale and serve more patients with higher quality at lower cost. He created and teaches the MIT Healthcare Ventures graduate courses within the pioneering Health Science & Technology (HST)program, a joint initiative between MIT, Harvard Medical School and the Boston academic hospitals. As faculty director for the HackingMedicine.MIT.edu health innovation leadership initiatives, Zen mentors physician entrepreneurs, early-stage startups and health corporations adapting to global digital healthcare transformation, changing healthcare incentives, growth in emerging markets, and new disruptive technologies that re-engineer medicine.As Managing Director of Accelerated Medical Ventures, Zen specializes in building early-stage medical technology and healthcare service companies, usually serving as co-founder and first investor. AMV’s portfolio spans Boston, Silicon Valley and China, including PillPack.com, Figure1.com, 3D-Matrix Medical [JASDAQ: 7777], Curoverse Genomics, PathFinder Regenerative Medicine [OTCQB: PFND], BitGym.com, Aptible, DirectDermatology.com and a couple of companies still in stealth mode.Alongside four world-renowned MIT biomaterials professors, Zen co-founded 3D-Matrix Medical Inc., serving as the first CEO for the venture-backed MIT regenerative medicine company whose injectable gel drug delivery products are treating patients and enabling new regenerative medicine research, with a successful IPO in 2011. He has managed and led new ventures for Harvard Medical School, Harvard’s Wyss Institute for Bioengineering, NetVentures and Hewlett-Packard.Zen earned a Masters of Public & Private Management from Yale University and a BS in biomedical/electrical engineering from SMU. He's married to another entrepreneur-turned-venture investor and they are raising three aspiring makers in Brookline, MA.

Investment focus

Health Care, Medical, mHealth
Series A, Seed
United States, Canada

Portfolio highlights

Filtricine — Transforming Cancer Management
Abridge — For patients, clinicians, and enterprise, our audio-based solutions capture the details and summarize medical conversations, anywhere care happens.
Lora DiCarlo Inc. — Lora DiCarlo used biomimicry to translate human mouth, tongue, and finger-like haptics into microrobotic mechanisms that feel like a human partner. Osé adjusts to each woman's unique physiology for a personal fit that makes achieving the elusive blended orgasm easy.